To the central content area
:::
:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

6446 PEC
中文
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Chingleou Teng Jack Hwang Ko-Chung Lin 02-26557688 13F, No.3, YuanQu St., NanKang Dist.,Taipei 115, Taiwan 2016/07/19
Industry Main Business
Biotechnology and Medical Care PharmaEssentia was founded in 2003 by a group of Taiwanese-American Executives and high-ranking scientists coming from leading biotech and pharmaceutical companies in the US. PharmaEssentia Corporation aims to deliver efficacious, safe and cost-effective therapeutic products for the treatment of human disease. At PharmaEssentia, our mission is a never-ceasing commitment to the improvement of health and quality of life, with a goal to be the first biotech company that discover, develop, and manufacture new drugs in Taiwan, aiming for market in Europe and US.
 
Market Information ( 2021/11/29 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
margin
balance
(1,000shr.)
Short
margin
balance
(1,000shr.)
1949.703 205.00  197.00  205.00  10.00  1332 0.73 N/A N/A
Trading method Fun
purchase
price or
securities
pneeded
on T day
Announcement of Irregularity
(2021/11/30)
TPEx measures
adopted
(2021/11/30)
With warrants Can be shorted or margined? Detail
變更交易 Y N Y N N Today History
 
Financial Reports
Cash Flows Items
Amount
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Balance
Sheets
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 More detail:MOPS
 Foreign issuers’ information is disclosed in consolidated statements.